Examples of how OncoSim has been used
Find examples of work that have used OncoSim for analyses or have cited OncoSim projections
Publishing or presenting results that include OncoSim analyses? Please notify us.
All cancers
- Exploring the Future of Cancer Impact in Alberta: Projections and Trends 2020–2040
- Future of Cancer Impact (FOCI) in Alberta
- Long-term projections of cancer incidence and mortality in Canada: The OncoSim All Cancers Model
- Cancer in Canada – Future Projections
- The Economic Burden of Cancer in Canada from a Societal Perspective
- Estimates of future cancer management costs attributable to modifiable risk factors in Canada
- Estimates of future cancer mortality attributable to modifiable risk factors in Canada
- Cancer burden attributable to risk factors
Breast cancer
- The OncoSim-Breast cancer microsimulation model
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
- The Value of All-Cause Mortality as a Metric for Assessing Breast Cancer Screening
- The OncoSim-Breast model reproduces the observed effects of a randomized screening trial
- Potential benefits of reducing breast cancer screening abnormal call rates
Cervical cancer/HPV
- Impact of the COVID-19 pandemic on the incidence and mortality of cervical cancer in Canada. Projections from OncoSim-HPV/Cervical cancer (IPV conference)
- Action plan for the elimination of cervical cancer
- Moving towards the elimination of cervical cancer: modeling the health and economic benefits of increasing HPV vaccine uptake
- Starting cervical cancer screening at 25 years of age: the time has come
- Exploring the health outcomes of various pan-Canadian cervical cancer screening programs using microsimulation modeling
- Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)
- Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada
- Evaluation of the natural history of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM) – Human papillomavirus and cervical components
Colorectal cancer
- COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study
- The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model
- Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim
- Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
- Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
- Participatory simulation modeling to inform colorectal cancer screening in a complex remote northern health system: Canada’s Northwest Territories
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
- Simulating Results from Trials of Sigmoidoscopy Screening Using the OncoSim Microsimulation Model
- Projected Effect of Fecal Immunochemical Test Threshold for Colorectal Cancer Screening on Outcomes and Costs for Canada using the OncoSim Microsimulation Model
- Recommendations on screening for colorectal cancer in primary care
- Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada
- Family history-based colorectal cancer screening
- Comparing the health and economic impacts of two screening strategies for colorectal cancer in Canada using the Cancer Risk Management Model (CRMM)
Lung cancer
- The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations
- Impact of organized lung screening in Canada
- Efficacy of Risk Prediction Models and Thresholds to Select Patients for Lung Cancer Screening
- Estimating the cost effectiveness and clinical impact of adding smoking cessation to an organized CT lung cancer screening program in Canada
- Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness
- Implementing low-dose computer tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency and duration
- Recommendations on screening for lung cancer
- Cost-effectiveness of lung cancer screening in Canada
- Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals
- Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada
- Low dose computed tomography for the screening of lung cancer in adults
- The evaluation of cancer control interventions in lung cancer using the Canadian Cancer Risk Management Model
- Costs and cost-effectiveness of smoking cessation within an organized CT lung cancer screening program
- How in the real world are lung cancer patients treated?
- Lung cancer-related clinical and economic impacts of achieving a 5% smoking rate by 2035 in Canada
- Comparing the health and economic outcomes of opportunistic lung cancer screening vs. organized lung screening using the Cancer Risk Management Model
- Annual vs. biennial lung cancer screening using the Cancer Risk Management Model to fill gaps in evidence
COVID-19 modelling
- Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
- Impact of the COVID-19 pandemic on FAECAL immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: A comparative modelling study
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
Other
- 2018 Cancer system performance report
- The OncoSim Model: Development and use for better decision-making in Canadian cancer control
- 2017 Cancer system performance report
- Quality and sustainability in cancer control: A system performance report
- Canadian Cancer Risk Management Model: Evaluation of cancer control
- Translating research to inform policy decisions